(Total Views: 136)
Posted On: 07/16/2020 2:15:48 PM
Post# of 35809

$APRE News Article - Aprea Therapeutics Announces Expansion of Clinical Trial Evaluating Eprenetapopt for the Front-Line Treatment of TP53 Mutant Acute Myeloid Leukemia (AML) https://marketwirenews.com/news-releases/apre...81186.html


My Twitter: WhyteStocks